Use of neuromuscular blocking agents in mechanically ventilated patients with COVID-19: A propensity score analysis
G. Li Bassi (Chermside, Australia), K. Gibbons (Brisbane, Australia), J. Suen (Chermside, Australia), H. Dalton (Falls Church, United States of America), N. White (Brisbane, Australia), A. Corley (Chermside, Australia), S. Hinton (Chermside, Australia), S. Forsyth (Brisbane, Australia), J. Laffey (Galway, Australia), D. Brodie (NY, United States of America), A. Burrell (Melbourne, Australia), E. Fan (Toronto, Canada), R. Bartlett (Ann Arbor, United States of America), A. Torres (Barcelona, Spain), D. Chiumello (Milan, Italy), A. Elhazmi (Riyadh, Saudi Arabia), C. Hodgson (Melbourne, Australia), S. Ichiba (Tokyo, Japan), C. Luna (Buenos Aires, Argentina), S. Murthy (Vancouver, Canada), A. Nichol (Dublin, Ireland), P. Ng (Hong Kong, China), M. Panigada (Milan, Italy), J. Fraser (Chermside, Australia)
Source: Virtual Congress 2021 – COVID-19 acute respiratory distress syndrome
Session: COVID-19 acute respiratory distress syndrome
Session type: Oral Presentation
Number: 1259
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Li Bassi (Chermside, Australia), K. Gibbons (Brisbane, Australia), J. Suen (Chermside, Australia), H. Dalton (Falls Church, United States of America), N. White (Brisbane, Australia), A. Corley (Chermside, Australia), S. Hinton (Chermside, Australia), S. Forsyth (Brisbane, Australia), J. Laffey (Galway, Australia), D. Brodie (NY, United States of America), A. Burrell (Melbourne, Australia), E. Fan (Toronto, Canada), R. Bartlett (Ann Arbor, United States of America), A. Torres (Barcelona, Spain), D. Chiumello (Milan, Italy), A. Elhazmi (Riyadh, Saudi Arabia), C. Hodgson (Melbourne, Australia), S. Ichiba (Tokyo, Japan), C. Luna (Buenos Aires, Argentina), S. Murthy (Vancouver, Canada), A. Nichol (Dublin, Ireland), P. Ng (Hong Kong, China), M. Panigada (Milan, Italy), J. Fraser (Chermside, Australia). Use of neuromuscular blocking agents in mechanically ventilated patients with COVID-19: A propensity score analysis. 1259
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Daily weanscreen in mechanically ventilated patients; effects on sedation, analgesics and duration Source: Annual Congress 2011 - The eclectic world of respiratory nursing Year: 2011
Prognostic value of residual hypoventilation in mechanically ventilated neuromuscular patients: A 5 years follow-up study Source: International Congress 2015 – Innovations in noninvasive ventilation: is it always gold that glitters? Year: 2015
An appraisal of respiratory system compliance in mechanically ventilated COVID-19 patients Source: Virtual Congress 2021 – Respiratory failure in COVID19 and beyond Year: 2021
Sedation in COPD patients mechanically ventilated due to acute respiratory failure: the prognostic effects of its duration more than 24 hours Source: Eur Respir J 2006; 28: Suppl. 50, 395s Year: 2006
Effectiveness of four early-rehabilitation techniques in sedated and ventilated patients in ICU Source: International Congress 2018 – Muscle adaptations in response to physiotherapeutic interventions in acute and chronic settings Year: 2018
Impact of sleep alterations on weaning duration in mechanically ventilated patients: a prospective study Source: Eur Respir J, 51 (4) 1702465; 10.1183/13993003.02465-2017 Year: 2018
Risk factors and prognostic impact of decreased breathing variability in mechanically ventilated patients. A prospective study Source: International Congress 2015 – Acute critical care: mechanical ventilation: how to limit the damage Year: 2015
Characteristics and outcomes of mechanically ventilated patients in an adult mixed ICU Source: Annual Congress 2009 - Intensive care unit management and outcome Year: 2009
Determination of the best threshold to initiate inspiratory muscle training in mechanically ventilated patients Source: Annual Congress 2008 - Mucociliary clearance, novel techniques and assessments, in adult, paediatric and mechanically ventilated patients Year: 2008
Feasibility and safety of a new method of broncoscopy in mechanically ventilated patients Source: Eur Respir J 2005; 26: Suppl. 49, 530s Year: 2005
Influence of respiratory infections on survival of mechanically ventilated patients Source: Eur Respir J 2004; 24: Suppl. 48, 547s Year: 2004
Nonlinear approach of respiratory mechanics in mechanically ventilated COPD patients Source: Eur Respir J 2001; 18: Suppl. 33, 481s Year: 2001
Impact of sleep alterations on weaning duration of mechanically ventilated patients: how much is bad? Source: Eur Respir J, 52 (1) 1800979; 10.1183/13993003.00979-2018 Year: 2018
Impact of sleep alterations on weaning duration of mechanically ventilated patients: how much is bad? Source: Eur Respir J, 52 (1) 1800925; 10.1183/13993003.00925-2018 Year: 2018
In vitro evaluation of a novel ventilation chamber (VC) for delivery of aerosolized medication to the mechanically ventilated premature infantSource: Annual Congress 2009 - New aspects of inhalation therapy Year: 2009
Risk factors and prognostic impact of patient-ventilator asynchrony in mechanically ventilated patients. A prospective study Source: International Congress 2015 – Acute critical care: mechanical ventilation: how to limit the damage Year: 2015
A new method to measure cough pressure in intubated patients. Validity and usefulness as a predictor of extubation failure in ICU patients having succeded a spontaneous breathing trial Source: Annual Congress 2013 –Mechanical ventilation and weaning Year: 2013
Treatment modalities in home mechanically ventilated patients. Report from a national database Source: Annual Congress 2005 - Chronic care in respiratory failure Year: 2005